Lyrica Capsule
Product Images NDC 58151-239

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Lyrica (NDC 58151-239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cockcroft And Gault Equation (Image 01)

FDA Label Image

Pregabalin Structural Formula (Image 02)

FDA Label Image

Figure 1: Patients Achieving Various Levels Of Improvement In Pain Intensity – Study Dpn 1 (Image 03)

FDA Label Image

Figure 2: Patients Achieving Various Levels Of Improvement In Pain Intensity– Study Dpn 2 (Image 04)

Figure 2: Patients Achieving Various Levels Of Improvement In Pain Intensity– Study Dpn 2 (Image 04)
This text appears to be a medication dosage instruction along with a measurement related to pain improvement. It is recommended to take 100 mg of Frogabain per day. Additionally, there seems to be a reference to the percentage of pain improvement from baseline.*
FDA Label Image

Figure 3: Patients Achieving Various Levels Of Improvement In Pain Intensity– Study Phn 1 (Image 05)

Figure 3: Patients Achieving Various Levels Of Improvement In Pain Intensity– Study Phn 1 (Image 05)
This text describes the percent of improvement in patients taking different doses of pregabalin multiple times a day compared to a placebo. It includes the improvement in pain from the baseline. The percentages of patients improved at various doses are listed in the text.*
FDA Label Image

Figure 4: Patients Achieving Various Levels Of Improvement In Pain Intensity – Study Phn 2 (Image 06)

Figure 4: Patients Achieving Various Levels Of Improvement In Pain Intensity – Study Phn 2 (Image 06)
This is a clinical trial data showing the percentage of patients' improvement in pain with different treatments: Pregabalin 200 mg three times a day, Pregabalin 100 mg three times a day, and Placebo. The text provides percentages of improvement in pain from baseline, indicating the efficacy of each treatment.*
FDA Label Image

Figure 5: Patients Achieving Various Levels Of Improvement In Pain Intensity– Study Phn 3 (Image 07)

FDA Label Image

Figure 6: Responder Rate By Adjunctive Epilepsy Study (Image 08)

FDA Label Image

Figure 7: Seizure Reduction By Dose (all Partial Onset Seizures) For Studies E1, E2, And E3 (Image 09)

FDA Label Image

Figure 8: Responder Rate (greater Than Or Equal To 50% Reduction) (Image 10)

FDA Label Image

Figure 9: Patients Achieving Various Levels Of Improvement In Pain Intensity – Fibromyalgia Study F1 (Image 11)

Figure 9: Patients Achieving Various Levels Of Improvement In Pain Intensity – Fibromyalgia Study F1 (Image 11)
This text mentions the percentage of patients improved after different daily doses of Pregabalin and Placebo. It also highlights the percentage improvement in pain from baseline.*
FDA Label Image

Figure 10: Time To Loss Of Therapeutic Response, Fibromyalgia Study F2 (kaplan-meier Analysis) (Image 12)

FDA Label Image

Figure 11: Patients Achieving Various Levels Of Improvement In Pain Intensity – Study Sci 1 (Image 13)

FDA Label Image

Figure 12: Patients Achieving Various Levels Of Improvement In Pain Intensity – Study Sci 2 (Image 14)

FDA Label Image

Lyrica Capsules 25 mg Bottle Label (Image 15)

Lyrica Capsules 25 mg Bottle Label (Image 15)
This text appears to be the package information for 90 capsules of Lyrica (pregabalin) containing 35mg of pregabalin in each capsule. The capsules should be stored at a temperature between 15-20°C (53-86°F). It emphasizes dispensing with a medication guide and advises referencing the prescribing information for dosage and usage instructions. This product is only available with a prescription.*
FDA Label Image

Lyrica Capsules 50 mg Bottle Label (Image 16)

Lyrica Capsules 50 mg Bottle Label (Image 16)
This text appears to be a prescription label for Lyrica (pregabalin) with instructions for storing at 25°C, the quantity of capsules (90), the drug name, and that it requires a prescription. It also mentions the need for a medication guide.*
FDA Label Image

Lyrica Capsules 75 mg Bottle Label (Image 17)

Lyrica Capsules 75 mg Bottle Label (Image 17)
This text appears to be a prescription label for a medication called Lyrica (pregabalin) in 75 mg capsules. It emphasizes the importance of dispensing with the medication guide and includes directions regarding dosage and use. The prescription is for 90 capsules and for prescription use only.*
FDA Label Image

Lyrica Capsules 100 mg Bottle Label (Image 18)

Lyrica Capsules 100 mg Bottle Label (Image 18)
This text provides important information about Lyrica capsules containing 100 mg of pregabalin. It advises to store at 25°C (77°F) and dispense in light-resistant containers. It is essential to dispense with the medication guide and contains 90 capsules for prescription use only.*
FDA Label Image

Lyrica Capsules 150 mg Bottle Label (Image 19)

Lyrica Capsules 150 mg Bottle Label (Image 19)
This text provides important information about storing pregabalin capsules, including the recommended temperature range and guidelines for dispensing in child-resistant containers. It also specifies the dosage strength of each capsule (150 mg) and the total quantity included in the packaging (90 capsules). Additionally, it emphasizes the necessity of providing a medication guide when dispensing Lyrica.*
FDA Label Image

Lyrica Capsules 200 mg Bottle Label (Image 20)

Lyrica Capsules 200 mg Bottle Label (Image 20)
Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). Dispense in tight, child-resistant containers. Each capsule contains 200 mg pregabalin. Always dispense with "MEDICATION GUIDE." 90 Capsules Rx only.*
FDA Label Image

Lyrica Capsules 225 mg Bottle Label (Image 21)

Lyrica Capsules 225 mg Bottle Label (Image 21)
This text provides information for storing Lyrica (pregabalin) capsules, recommending storage at 25°C with excursions between 15-30°C. It specifies dispensing in tight, child-resistant containers and mentions each capsule contains 225 mg of pregabalin. It advises to dispense with medication guide and states that 90 capsules are available by prescription only.*
FDA Label Image

Lyrica Capsules 300 mg Bottle Label (Image 22)

Lyrica Capsules 300 mg Bottle Label (Image 22)
Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) (see USP Controlled Room Temperature). This medication contains 300 mg of pregabalin per capsule and comes in a pack of 90 capsules. Remember to dispense in tight (USP) capsules. Please refer to the accompanying prescribing information and always dispense with the Medication Guide. Make sure to keep the medication at the recommended temperature range.*
FDA Label Image

Lyrica Oral Solution 20 mg Per mL Carton Label (Image 23)

Lyrica Oral Solution 20 mg Per mL Carton Label (Image 23)
This text provides information about Lyrica (pregabalin) oral solution, with a concentration of 20 mg per mL in a 16 fl oz (473 mL) container. It gives storage instructions, dosage guidance, and indicates that it is available by prescription only. It is important to follow the recommended storage conditions and dosage instructions provided for this medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.